Indeed, heterozygous SETD2 loss in leukemia cells expressing a MLL (Mixed Lineage Leukemia)-AF9 fusion protein was found to accelerates leukemogenesis driven by the MLL fused gene. The gene discussed is MLLT3; the disease is leukemia.